Literature DB >> 2909522

Location of the antithrombin-binding sequence in the heparin chain.

L G Oscarsson1, G Pejler, U Lindahl.   

Abstract

The antithrombin-binding region of heparin is a pentasaccharide sequence with the predominant structure -GlcNAc(6-OSO3)-GlcA-GlcNSO3(3,6-di-OSO3)-Ido A(2-OSO3)- GlcNSO3(6-OSO3)-. By using the 3-O-sulfated glucosamine residue as a marker for the anti-thrombin-binding sequence, the location of this sequence within the heparin chain was investigated. Heparin with high affinity for antithrombin (HA-heparin) contains few N-acetyl groups located outside the antithrombin-binding region, and cleavage at such groups was therefore expected to be essentially restricted to this region. HA-heparin was cleaved at N-acetylated glucosamine units by partial deacetylation followed by treatment with nitrous acid at pH 3.9, and the resulting fragments with low affinity for anti-thrombin (LA-fragments) were recovered after affinity chromatography on immobilized antithrombin. The LA-fragments were further divided into subfractions of different molecular size by gel chromatography and were then analyzed with regard to the occurrence of the nonreducing terminal GlcA-GlcNSO3(3,6-di-OS-O3)- sequence. Such units were present in small, intermediate-sized as well as large fragments, suggesting that the antithrombin-binding regions were randomly distributed along the heparin chains. In another set of experiments, HA-heparin was subjected to limited, random depolymerization by nitrous acid (pH 1.5), and the resulting reducing terminal anhydromannose residues were labeled by treatment with NaB3H4. The molecular weight distributions of such labeled LA-fragments, determined by gel chromatography, again conformed to a random distribution of the antithrombin-binding sequence within the heparin chains. These results are in apparent disagreement with previous reports (Radoff, S., and Danishefsky, I. (1984) J. Biol. Chem. 259, 166-172; Rosenfeld, L., and Danishefsky, I. (1988) J. Biol. Chem. 263, 262-266) which suggest that the antithrombin-binding region is preferentially located at the nonreducing terminus of the heparin molecule.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2909522

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Molecular-size-dependent variations in the proportions of chains with high binding affinities for antithrombin in rat skin heparin proteoglycans.

Authors:  A A Horner
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

2.  A method for the sequence analysis of dermatan sulphate.

Authors:  L A Fransson; B Havsmark; I Silverberg
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

3.  Isolation and characterization of a heparin with low antithrombin activity from the body of Styela plicata (Chordata-Tunicata). Distinct effects on venous and arterial models of thrombosis.

Authors:  Joana C Santos; Juliana M F Mesquita; Celso L R Belmiro; Carolina B M da Silveira; Christian Viskov; Pierre A Mourier; Mauro S G Pavão
Journal:  Thromb Res       Date:  2007-05-04       Impact factor: 3.944

Review 4.  Therapeutically targeting protein-glycan interactions.

Authors:  A Rek; E Krenn; A J Kungl
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

5.  Sequence analysis of heparan sulphate indicates defined location of N-sulphated glucosamine and iduronate 2-sulphate residues proximal to the protein-linkage region.

Authors:  J E Turnbull; J T Gallagher
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

6.  De novo synthesis of a narrow size distribution low-molecular-weight heparin.

Authors:  Kasemsiri Chandarajoti; Yongmei Xu; Erica Sparkenbaugh; Nigel S Key; Rafal Pawlinski; Jian Liu
Journal:  Glycobiology       Date:  2014-03-13       Impact factor: 4.313

7.  A French National Survey on Clotting Disorders in Mastocytosis.

Authors:  Ana B Carvalhosa; Achille Aouba; Gandhi Damaj; Danielle Canioni; Chantal Brouzes; Emmanuel Gyan; Stéphane Durupt; Isabelle Durieu; Pascal Cathebras; Nathalie Costédoat-Chalumeau; David Launay; Benoit Pilmis; Stephane Barete; Laurent Frenzel; Olivier Lortholary; Olivier Hermine; Cedric Hermans; Marie-Olivia Chandesris
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.